George Adi Mor, Chief Scientific Officer at Chemomab Therapeutics Ltd. (CMMB), sold 13,800 shares at $5.03 ($69K) on 2023-01-03, disclosed to the SEC on 2023-01-05.
Scheduled sale ($69k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.03 | 6,100 | $31K | 44.2% |
| 2 | $5.03 | 7,700 | $39K | 55.8% |
| Total | $5.03 avg | 13,800 | $69K | 100% |
| Filing → |